Avadel Pharmaceuticals plc
AVDL
Market Cap$891.42M
Close$
$-0.46
105.2% downside
Current Fair Value
105.2% downsideOvervalued by 105.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $891.42 Million |
|---|---|
| Enterprise Value | $847.06 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.51 |
| Beta | 1.45 |
| Outstanding Shares | 96,601,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -33.65 |
|---|---|
| PEG | 41.04 |
| Price to Sales | 4.43 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.36 |
| Enterprise Value to EBIT | -46.21 |
| Enterprise Value to Net Income | -33 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Avadel Pharmaceuticals plc
CEO: Gregory Divis